AD

Andrew Dunham

Chief Technology Officer

Hemanext

Chicago, Illinois


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Hemanext
Industry
medical devices
Employees
32.0
Seniority
C suite
Annual Revenue
6000000.0
Total Funding
85970000.0
Latest Funding
Series B

Technologies

SendInBlue Outlook Microsoft Office 365 Leadfeeder DigitalOcean WordPress.org Mobile Friendly Apache Ubuntu reCAPTCHA Google Font API Google Tag Manager Remote

Keywords

medical equipment manufacturing transfusion medicine red blood cell processing rbc storage technology rbc storage lesion hypoxic storage fda authorized medical device blood storage optimization enhanced oxygen delivery blood product innovation medical technology blood transfusion safety biomedical advancements clinical trials blood donation storage viability cell function preservation oxygen depletion in rbcs patient care improvement healthcare solutions biochemical stability blood component separation medical device manufacturing rbc quality enhancement medical research hemaglobin management blood compatibility anemia treatment patient blood management leukocyte reduction oxygen care systems transfusion therapy advancement blood bank technology risk reduction in transfusions clinical efficacy biological integrity oxygen saturation monitoring red blood cell assessment storage time impact clinical research partnerships regulatory compliance investor relations global healthcare partnerships blood management systems safety studies blood resilience cost-effective solutions medical device regulation innovative health technologies medical devices hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans